1-241532484-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000366559.9(KMO):āc.40A>Gā(p.Ile14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000498 in 1,609,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000366559.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KMO | NM_003679.5 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | ENST00000366559.9 | NP_003670.2 | |
KMO | NM_001410944.1 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | NP_001397873.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KMO | ENST00000366559.9 | c.40A>G | p.Ile14Val | missense_variant | 1/15 | 1 | NM_003679.5 | ENSP00000355517 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000342 AC: 52AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000246 AC: 61AN: 247558Hom.: 0 AF XY: 0.000261 AC XY: 35AN XY: 134032
GnomAD4 exome AF: 0.000514 AC: 749AN: 1457494Hom.: 0 Cov.: 30 AF XY: 0.000506 AC XY: 367AN XY: 725218
GnomAD4 genome AF: 0.000341 AC: 52AN: 152308Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.40A>G (p.I14V) alteration is located in exon 1 (coding exon 1) of the KMO gene. This alteration results from a A to G substitution at nucleotide position 40, causing the isoleucine (I) at amino acid position 14 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at